X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE STERLING BIOTECH SUVEN LIFE/
STERLING BIOTECH
 
P/E (TTM) x 15.9 -1.8 - View Chart
P/BV x 3.0 0.1 4,153.5% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SUVEN LIFE   STERLING BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
STERLING BIOTECH
Dec-13
SUVEN LIFE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs33911 3,223.8%   
Low Rs1443 4,247.1%   
Sales per share (Unadj.) Rs39.226.8 146.4%  
Earnings per share (Unadj.) Rs7.5-15.0 -49.9%  
Cash flow per share (Unadj.) Rs8.8-5.5 -160.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.054.9 89.3%  
Shares outstanding (eoy) m127.28267.87 47.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.20.3 2,373.0%   
Avg P/E ratio x32.4-0.5 -6,964.0%  
P/CF ratio (eoy) x27.5-1.3 -2,162.7%  
Price / Book Value ratio x4.90.1 3,891.3%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,7321,862 1,650.7%   
No. of employees `0001.01.4 70.5%   
Total wages/salary Rs m416547 76.2%   
Avg. sales/employee Rs Th5,236.15,303.3 98.7%   
Avg. wages/employee Rs Th436.5403.8 108.1%   
Avg. net profit/employee Rs Th995.5-2,959.0 -33.6%   
INCOME DATA
Net Sales Rs m4,9957,181 69.6%  
Other income Rs m19443 454.2%   
Total revenues Rs m5,1897,223 71.8%   
Gross profit Rs m1,233947 130.2%  
Depreciation Rs m1672,543 6.6%   
Interest Rs m544,377 1.2%   
Profit before tax Rs m1,205-5,931 -20.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255-1,924 -13.3%   
Profit after tax Rs m950-4,007 -23.7%  
Gross profit margin %24.713.2 187.1%  
Effective tax rate %21.232.4 65.2%   
Net profit margin %19.0-55.8 -34.1%  
BALANCE SHEET DATA
Current assets Rs m4,98614,335 34.8%   
Current liabilities Rs m1,04249,809 2.1%   
Net working cap to sales %79.0-494.0 -16.0%  
Current ratio x4.80.3 1,662.3%  
Inventory Days Days61403 15.1%  
Debtors Days Days39171 22.9%  
Net fixed assets Rs m3,12655,432 5.6%   
Share capital Rs m127268 47.5%   
"Free" reserves Rs m3,71713,935 26.7%   
Net worth Rs m6,23614,701 42.4%   
Long term debt Rs m4329,478 4.6%   
Total assets Rs m8,07973,988 10.9%  
Interest coverage x23.2-0.4 -6,543.5%   
Debt to equity ratio x0.10.6 10.8%  
Sales to assets ratio x0.60.1 637.1%   
Return on assets %12.40.5 2,480.7%  
Return on equity %15.2-27.3 -55.9%  
Return on capital %18.9-6.4 -293.8%  
Exports to sales %87.525.9 337.8%   
Imports to sales %12.20.2 7,197.3%   
Exports (fob) Rs m4,3711,860 235.0%   
Imports (cif) Rs m61112 5,006.7%   
Fx inflow Rs m4,6661,860 250.9%   
Fx outflow Rs m94225 3,785.1%   
Net fx Rs m3,7241,835 203.0%   
CASH FLOW
From Operations Rs m9221,719 53.6%  
From Investments Rs m-619-3,148 19.7%  
From Financial Activity Rs m-6981,426 -49.0%  
Net Cashflow Rs m-396-3 11,638.2%  

Share Holding

Indian Promoters % 63.4 33.9 187.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 36.5 39.3 92.9%  
Shareholders   37,287 21,482 173.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  ALKEM LABORATORIES  AJANTA PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 16, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - SANOFI INDIA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS